Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer.

Aim: To investigate the efficacy and safety of bevacizumab in patients with recurrent low-grade serous ovarian carcinoma. Materials & methods: The data of patients who received at least two cycles of bevacizumab in combination with chemotherapy were retrospectively recorded. Results: The median age of 51 patients was 56 (range: 33-75) years. The complete response rate was 10.4% and the partial response rate was 43.7%. The objective response rate was 54.1%. Median progression-free survival was 15.9 months (95% CI: 9.1-22.6) and median overall survival was 42.5 months (95% CI: 37.2-47.8). Conclusion: Bevacizumab with chemotherapy is an effective option for treating recurrent ovarian low-grade serous carcinoma.

PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study.

INTRODUCTION: In this study, the toxicities and management of palbociclib and ribociclib in older patients (≥65 years) with metastatic breast cancer patients were investigated. MATERIALS AND METHODS: Among older patients receiving palbociclib and ribociclib, Geriatric 8 (G8) and Groningen Frailty Index were used to evaluate frailty status. Dose modifications, drug withdrawal and other serious adverse events (SAEs) were recorded and analyzed according to baseline patient characteristics. RESULTS: A total of 160 patients from 28 centers in Turkey were included (palbociclib = 76, ribociclib = 84). Forty-three patients were ≥ 75 years of age. The most common cause of first dose modification was neutropenia for both drugs (97% palbociclib, 69% ribociclib). Liver function tests elevation (10%) and renal function impairment (6%) were also causes for ribociclib dose modification. Drug withdrawal rate was 3.9% for palbociclib and 6% for ribociclib. SAEs were seen in 11.8% of those taking palbociclib and 15.5% of those on riboclib. An ECOG performance status of ≥2 and being older than 75 years were associated with dose reductions. Severe neutropenia was more common in patients with non-bone-only metastatic disease, those receiving treatment third-line therapy or higher, coexistance of non-neutropenic hematological side effects (for ribociclib). Neutropenia was less common among patients with obesity. DISCUSSION: Our results show that it can be reasonable to start palbociclib and ribociclib at reduced dose in patients aged ≥75 years and/or with an ECOG performance status ≥2.

Effect of phosphoric acid etching and self-etching primer application methods on dentinal shear bond strength.

PURPOSE: To evaluate acid-etching effects prior to the application of self-etching primer and the effect of different primer application techniques on dentin shear bond strength (SBS). MATERIALS AND METHODS: Forty human third molar cervical regions were used in this study. The teeth were randomly divided into four groups (n=10) of different tooth surface conditions: group A: Clearfil Protect Primer applied gently (inactive) + Clearfil Protect Bond; group B: 38% phosphoric acid for 15 s, rinsed 15 s, and dried 15 s + Clearfil Protect Primer applied gently (inactive) + Clearfil Protect Bond; group C: Clearfil Protect Primer applied with agitation by microapplicator brush (active) + Clearfil Protect Bond; group D: 38% phosphoric acid for 15 s, rinsed 15 s, and dried 15 s + Clearfil Protect Primer applied with agitation by microapplicator brush (active) + Clearfil Protect Bond. The SBS test was performed with a universal testing machine at a crosshead speed of 1 mm/min. Data were analyzed with one-way ANOVA and Tukey HSD tests. RESULTS: The mean SBS values (MPa) and standard deviations are as follows: group A: 36.0 +/- 8.3; group B: 24.0 +/- 3.9; group C: 35.0 +/- 3.3; group D: 30.6 +/- 6.7. CONCLUSION: Acid etching decreased the SBS of the self-etching bonding system to dentin. Active primer application increased the SBS only in acid-etched groups.

Evaluation of the effect of different ferrule designs on the fracture resistance of endodontically treated maxillary central incisors incorporating fiber posts, composite cores and crown restorations.

AIM: The purpose of this study was to evaluate the fracture resistance of endodontically treated maxillary central incisors restored with quartz fiber posts, composite cores, and crowns when different types of ferrule designs were incorporated. METHODS AND MATERIALS: Sixty maxillary incisors were divided into six groups: Group 1 (control): teeth with root canal treatments having a full crown prosthesis; Group 2: teeth with a 2 mm circumferential ferrule; Group 3: teeth with a 2 mm ferrule only in the vestibular region; Group 4: teeth with a 2 mm ferrule only in the palatal region; Group 5: teeth with a 2 mm ferrule in the vestibular and palatal region, having cavities in both proximal areas; and Group 6: teeth with no ferrule. The teeth in the experimental groups were restored with quartz fiber posts-composite cores and full metallic crowns. All experimental teeth were subjected to an increasing compressive force with a crosshead speed of 1 mm/min, until fracture occurred. RESULTS: The median fracture values of groups were as follows: Group 1: 574.4 N, Group 2: 472.4 N, Group 3: 474.3 N, Group 4: 480.7 N, Group 5: 463.1 N, and Group 6: 297.9 N. A statistically significant difference was found between Group 1 and Group 6 (p< 0.01). CONCLUSION: It was concluded different ferrule designs did not have any influence on the fracture resistance of teeth with fiber posts. The results of this study indicate fiber posts can safely be used for their reinforcing properties. Furthermore, there is no significant change in the resistance of teeth with fiber posts regardless of which ferrule design is incorporated. The property of these types of posts is an additional advantage in clinical practice.

Abdominal Inflammatory Myofibroblastic Tumor: A Rare Case.

An inflammatory myofibroblastic tumor, also known as inflammatory pseudotumor, is a rare neoplasm characterized by myofibroblastic spindle and inflammatory cells that cause masses in many sites of body. It is often benign, but in some cases neoplastic transformation has been reported as a result of aggressive growing. In our case, an inflammatory myofibroblastic tumor was reported by biopsy of a 25 × 15 cm abdominal mass. HOW TO CITE THIS ARTICLE: Tastekin F, Ersoy M, Temel T, Ozgenel SM, Canaz F, Özakyol A. Abdominal Inflammatory Myofibroblastic Tumor: A Rare Case. Euroasian J Hepato-Gastroenterol 2016;6(2):183-185.

Wear and microhardness of different resin composite materials.

This study determined the three-body abrasive wear resistance of two packable composites (P-60; Solitaire 2), an ion-releasing composite (Ariston AT), a hybrid composite (Tetric Ceram) and an ormocer (Admira). The study also looked at the correlation between wear resistance and hardness of the composites. Three-body wear testing was performed using an ACTA wear machine with 15 N contact force using millet seed as the third body. Wear depth (microm) was measured by profilometry after 200,000 cycles. The hardness test was performed using a digital microhardness tester (load: 500 g; dwell time: 15 seconds). The data were analyzed by using Kruskal Wallis (p < 0.05). There were statistically significant differences among the three body abrasive wear of the composites. The ranking from least to most were as follows: Filtek P-60 < Solitaire 2 < Ariston AT < Tetric Ceram < Admira. Filtek P-60 showed the highest microhardness value. No other significant differences in hardness were observed among the different resin composites (P-60 > AristonAT = Tetric Ceram = Solitaire 2 = Admira). The results of this study indicate that there are significant differences in the wear resistance of the resin composites. The correlation between hardness and wear was significant with a correlation coefficient of r:-0.91. A significant negative correlation exists between hardness and three-body wear of resin composites.

Physical properties of different composites.

The purpose of this study was to determine the flexural strength (FS), flexural modulus (FM), depth of cure (DC), polymerization shrinkage (PS), and microhardness (VH) of the following composites: Two packable composites--Filtek P-60 and Solitaire 2; One ion-releasing composite--riston AT; and Two hybrid composites--Charisma and Filtek Z-250. Data of the different tests conducted were obtained as follows: FS and FM data were determined with a universal-testing machine; Polymerization shrinkage was determined using the apparatus of Watts and Cash; Depth of cure was measured with a micrometer (Mitotuyo, UK); and Microhardness was measured with a Shimadzu Microhardness tester (500 g, 15 seconds). All data of the different tests were statistically analyzed by one-way variance analysis (ANOVA), which yielded the following results: Filtek Z-250 showed the statistically highest flexural strength and modulus values. Solitaire 2 exhibited the highest shrinkage, while the volumetric shrinkage results of Filtek Z-250 and Filtek P-60 ranked the lowest. For depth of cure, there were no statistically significant differences among all materials tested (p<0.05). Microhardness results revealed the following tendency: Filtek Z-250 = Filtek P-60 > Ariston AT = Solitaire 2 = Charisma.

A comparison of four different microleakage tests for assessment of leakage of root canal fillings.

OBJECTIVE: The purpose of this study was to compare four different microleakage tests (dye leakage, electrochemical test, bacterial test and fluid filtration) for evaluation of the coronal seal of teeth obturated using Thermafil or lateral condensation techniques. STUDY DESIGN: One hundred forty-four extracted single-rooted teeth were selected and prepared. The specimens were divided into 8 experimental groups. In 4 groups the root canals were filled with Thermafil obturators and in the other 4 groups by the lateral condensation technique. Coronal microleakage was assessed after exposing one group of specimens (n = 15 teeth) from each of the obturation techniques to each of the four microleakage tests. RESULTS: In the fluid filtration test, lateral condensation showed statistically less leakage than the Thermafil technique (P < .05). Electrochemical and dye leakage test results showed no difference between the two obturation techniques (P < .05). However, in the bacterial leakage test, Thermafil showed less leakage than lateral condensation (P < .05). CONCLUSION: There is poor correlation between various methods to evaluate hydraulic leakage. The clinical significance of leakage tests in vitro is questionable.